Four differently modified forms of acyl-CoA-binding protein (ACBP) were identified in ACBP purified from bovine liver. The majority of the purified ACBP was focused at pH 5.9 in isoelectric focusing and could be shown to be N-acetylated ACBP without any further modifications. Two minor peaks were focused at pH 5.25 and 4.85 respectively. Mass spectrometry and sequence determination showed that the pI 5.25 form was acetylated at Lys"8 and that the pI 4.85 form was malonylated in the same position. Furthermore, it could be shown that non-enzymic glycosylation occurred during purification. The acetylated and malonylated variants of ACBP were only found in adult cattle.
INTRODUCTION
Acyl-CoA-binding protein (ACBP) from bovine liver was originally purified and identified by Mogensen et al. (1987) . Bovine and rat liver ACBPs have been characterized in detail by Mikkelsen et al. (1987) and Knudsen et al. (1989) respectively. Both proteins are N-acetylated and have 86 amino acids. The average molecular mass values are 9955 and 9932 Da for bovine and rat ACBP respectively. ACBP has recently been shown to be identical to diazepam-binding inhibitor (DBI) (Knudsen & Nielsen, 1990 ) which has been characterized from a number of species. Comparison of the amino acid sequences of ACBP/DBI between species shows a strong degree of identity (Knudsen, 1991) .
When purifying ACBP from bovine liver by ion-exchange chromatography, three ACBP-containing peaks were observed in addition to the main peak. The aim of the present study was to determine the ways in which the ACBP variants found in the minor peaks differed from the N-acetylated ACBP characterized in detail by Mikkelsen et al. (1987) .
MATERIALS AND METHODS

Enzymes and special reagents
Bovine livers were obtained from the local slaughterhouse. Sephadex G-50, Sephadex G-100 material and Q-Sepharose-HP column were from Pharmacia, Uppsala, Sweden. Nucleosil ODS (10 ,um particle size; 10 nm pore size) and Nucleosil ODS (10 ,um particle size; 30 nm pore size) were from Machery-Nagel, Duren, Germany. Staphylococcus aureus V8 proteinase (EC 3.4.21.19) was from Miles Laboratories. Propan-2-ol (h.p.l.c. grade) and trifluoracetic acid (gas-phase Sequenator grade) were from Rathburn, Walkerburn, Scotland, U.K. All other chemicals used in this study were of analytical grade and were obtained either from E. Merck or from Ferrak, Berlin, Germany.
Purification of ACBP
ACBP was purified from bovine liver either as described by Hach et al. (1990) or as follows in order to prevent non-enzymic glycosylation. Bovine liver (50-100 g) was homogenized in 3 vol. of 154 mM-KCl and centrifuged at 13000 g for 30 min. The supernatant was further centrifuged at 105g for 60 min. The supernatant was incubated with 1 mmol of [3H]oleic acid (sp. radioactivity 4.8 mCi/mol) for 15 min under gentle stirring and then pumped directly on to a Sephadex G-50 (Superfine grade) column (80 cm x 5 cm). The column was equilibrated and eluted with 30 mM-Tris/HCI (pH 9.0)/0.02% NaN3 (flow rate 120 ml/h). The eluate was collected in fractions of 12 ml. Radioactivity was determined in 200,u1 of each fraction by liquid-scintillation counting. The radioactivity-containing peak representing fatty acid-binding proteins was localized, pooled and loaded on to a Q-Sepharose-HP ion-exchange column (20 cm x 1.6 cm) equilibrated with 30 mM-Tris/HCl, pH 9.0. The proteins were eluted with a gradient of NaCl in 30 mM-Tris/HCI, pH 9.0: 0 M for 5 min, 0 to 40 mM for 40 min, at 40 mM for 15 min, 40 to 100 mm for 60 min and 100 to 400 mm for 5 min. The flow rate was 4 ml/min. E.l.i.s.a. of ACBP ACBP was assayed by a multiple-layer enzyme-linked immunochemical procedure essentially as described by Pawlak & Smith (1986) , except that reaction of ACBP with immobilized rabbit anti-ACBP was carried out in 10 mM-Tris/HCI (pH 9.0)/0.5 MNaCI/2.6 mM-KCI/0.1 % BSA/0.02 % NaN3 overnight at 4 'C. The layers, attached sequentially to a 96-well plastic plate, consisted of monospecific rabbit anti-ACBP IgG, ACBP, biotinylated rabbit anti-ACBP IgG, avidin and biotinylated alkaline phosphatase; the chromogenic substrate was p-nitrophenyl phosphate.
Electrophoresis and isoelectric focusing
All electrophoretic and isoelectric focusing analyses were performed on a Pharmacia Phast System with either 20 %-(w/v)-acrylamide gels or isoelectric focusing gels with Ampholytes for the pH range 3-9. The analyses were carried out as recommended by the manufacturer. The Pharmacia broad pI (EIF3-9) calibration hit was used.
Digestion with V8 proteinase A 0.5 mg portion of ACBP was dissolved in 0. The incubation time was either 25 h at 50°C or 72 h at 37 'C. The samples were lyophilized and the peptides were repurified as described above.
Mass spectrometry
The molecular mass values of the peptides were determined on a Biolon BIN 10K plasma-desorption time-of-flight (p.d.) mass spectrometer. The samples were dissolved in 0.1 0% (v/v) trifluoroacetic acid, and 2.5,u (corresponding to 20-50 pmol of peptide) was applied on to an aluminized Mylar foil target coated with nitrocellulose and spin-dried (Nielsen et al., 1988) . After insertion of the sample in the mass spectrometer, it was bombarded with fission fragments from a 10 tCi 2"2Cf source. The mass spectra of the peptides were recorded for 5 x 105 primary ions.
Determination of amino acid sequences
Peptides were sequenced on a Knauer 810 pulsed-liquid sequencer with chemicals and program as recommended by the manufacturer. A 0.5-2 nmol portion of peptide was used for each sequence run, and the amino acid phenylthiohydantoin derivatives were identified on a Knauer on-line h.p.l.c. 64 using a 250 mm x 4 mm Lichrosphere 100 C-18 (5 ,um particle size) column and a gradient of acetonitrile in 50 mM-sodium acetate buffer, pH 5.2, as described by the manufacturer.
RESULTS AND DISCUSSION
The original purification procedure for ACBP developed by Mikkelsen et al. (1987) only contained three chromatography steps: chromatography on Sephadex G-100, followed by a Sephadex G-50 Superfine column and finally a reverse-phase h.p.l.c. step. The purified ACBP showed only a single band on SDS/PAGE (Mikkelsen et al., 1987) .
In later experiments the pure ACBP from the reserve-phase column was separated on a Q-Sepharose HP ion-exchange column, and to our surprise the ACBP separated into four peaks (Fig. 1) , all of which reacted with monospecific rabbit anti-(bovine ACBP). Q-Sepharose ion-exchange chromatography of the ACBP-containing peak from Sepharose G-50 showed the same result (results not shown), indicating that bovine liver contains more than one type of ACBP or differentially modified ACBP species.
In order to further characterize the additional three ACBPcontaining peaks, they were subjected to isoelectric focusing in a pH 3-9 gradient. Peaks II and III contained two major bands focusing at pH 5.9 and 5.25, and peak IV contained in addition a band focusing at pH 4.85. When incubated with hexadecanoylCoA prior to focusing, all bands focused at pH 4.55. The fact that all the bands were able to bind hexadecanoyl-CoA further indicates that the three additional peaks from the ion-exchange column represent ACBP variants.
When the pooled fractions from peaks II, III and IV respectively, were subjected to reverse-phase h.p.l.c., they all split up in two major peaks (results not shown). These peaks were further characterized by peptide mapping.
The primary structure of ACBP has been determined (Mikkelsen et al., 1987) and is shown in Fig. 2 . The Figure also shows the known V8 proteinase cleavage sites (reacting at pH 4.0), designated Sal etc.
The individual peaks from the h.p.l.c. separations of peaks II, III and IV from the Q-Sepharose column were digested with V8 proteinase, the individual peptides were isolated by h.p.l.c. and the molecular masses were determined by p.d.m.s. In addition to the well-known peaks in the V8 proteinase map of ACBP (Fig.  3a) , the map of peaks Ilb, IlIb and IVb contained an extra peak (marked X in Fig. 3b ). The additional peak at the beginning of the chromatogram is an impurity, which also occasionally appears in peptide maps of ACBP at pl 5.9.
The mass determination of the V8 proteinase peptides showed that the mass of some peptides was different from that expected. A number of peptides from all ACBP variants showed a peak for both the expected molecular mass and the expected mass+ 162 Da in p.d.m.s. (results not shown). The mass of peptide X from peaks Ilb, IlIb and IVb was 42 Da higher than the expected mass of Sa3 (see Fig. 2 ). Peptide X was subjected to Edman degradation, and it could be shown to be Sa3 (Val"2-Lys23) modified in Lys"8. Glu-Met-Leu-Phe-Ile-Tyr-Ser-His-Tyr-Lys-Gln-Ala-Thr-Val-Gly-Asp-Ile-Asn-Thr-Glu-Arg-Proft Sa4
Gly-Met-Leu-Asp-Phe-Lys-Gly-Lys-Ala-Lys-Trp-Asp-Ala-Trp-Asn-Glu-Leu-Lys-Gly-Thr-Ser-Lysftr Sa5
Glu-Asp-Ala-Met-Lys-Ala-Tyr-Ile-Asp-Lys-Val-Glu-Glu-Leu-Lys-Lys-Lys-Tyr-Gly-11e- between Sa3 and peptide X strongly indicates that Lys"8 is acetylated in the latter.
The 162 Da mass increase cannot be explained by exchange of one amino acid for another or by a post-translational modification where an amino acid is attached to the protein. However, non-enzymic glycosylation is a post-translational modification that could give rise to a mass increase of 162 Da. Non-enzymic glycosylation is the reaction where a glucose molecule is bound to a lysine residue through an amide bond. When a peptide which showed the 162 Da mass increase was subjected to Edman degradation, it could be shown that the lysine residues had been modified. However, the modification was never located to one single lysine residue but was evenly distributed over all the lysine residues in the peptide. The normal procedure for purifying ACBP exposes ACBP to rather harsh conditions, including freeze-drying, heat treatment and acid precipitation, and it is possible that the non-enzymic glycosylation arises as a result of these treatments. To verify that ACBP might be non-enzymically glycosylated during purification, we incubated peptide Sa3 from native ACBP with glucose as described in the Materials and methods section. The results showed that it is possible to 1 2 3 4 Fig. 5 . Isoelectric focusing of the ACBP-containing peaks from Fig. 4 Approx. ,tg of protein from each peak was subjected to isoelectric focusing. peaks, of which the major peak again could be shown to be native N-acetylated ACBP (Fig. 4) . To clarify whether the ACBP variants seen after the milder purification method were the same as described above, ACBPs from all three ACBP-containing peaks were purified to homogeneity by reserve-phase h.p.l.c. and subjected to isoelectric focusing. The three ACBP variants had different isoelectric points, pl 4.85, pI 5.25 and pl 5.9 (Fig. 5) . The variants were digested by V8 proteinase. The peptide map of the pl 5.9 variant was identical with that of native ACBP (Fig. 3a) found, which indicates that the non-enzymically glycosylated variants were artefacts that arose during the purification method of Hach et al. (1990) . To show that the presence of the two ACBP variants was not an isolated event, liver homogenates from four different animals were examined. The animals were two cows, a bull and a young calf. Purification of ACBP from adult animals showed that both ACBP variants were present. The amount of each variant relative to the amount of the native ACBP pl 5.9 form was similar for all animals. However, when liver from the young calf was examined, only native ACBP could be found.
Neither the acetylation nor the malonylation of ACBP affected its binding affinity for acyl-CoA esters. This question was examined by use of e.p.r. Using this technique we compared the ability of hexadecanoyl-CoA to displace 12-doxyloctadecanoylCoA from the three ACBP variants. It was shown that the Lys'8-acetylated and -malonated variant has exactly the same affinity for 12-doxyloctadecanoyl-CoA as native ACBP (results not shown). It could therefore be concluded that the binding affinity of ACBP is not altered by modification of Lys 8.
Another point which raises the question of whether the modification of Lys'8 is of general importance in regulating ACBP activity is the fact that this lysine residue is not conserved in all known ACBP forms, as the murine ACBP (Owens et al., 1989) and the rat ACBP (Knudsen et al., 1989 ) have a glutamine residue in this position. The mechanism of acetylation and malonylation in vivo is unknown; it could be spontaneous, enzymic or part of an unknown enzymic activity exerted by bovine ACBP. The physiological significance, if any, of these modifications in bovine liver ACBP is therefore an open question. In this connection, it is interesting that both the pl 5.25 and pl 4.85 variants are found in bovine brain in the same proportions as in the liver (J. Knudsen, unpublished work) .
